![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/25/2903709/34825/en/New-Study-From-Inovalon-and-Genentech-Finds-Racial-Disparities-In-Emergency-Department-Visits-For-Liver-Cancer-Care.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761053
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761388
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103792
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761106
https://www.fiercebiotech.com/cro/digital-medicine-society-partners-pharma-giants-new-digital-endpoints-project
https://pharmaphorum.com/news/italy-starts-probe-lucentis-biosimilar-delay-allegation
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-others-face-italy-antitrust-probe-over-eye-drug-2024-06-06/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-5-2024-58484.pdf